Terms: = Leukemia AND TFRC, P02786, 7037, ENSG00000072274, TFR1, CD71 AND Treatment
51 results:
1. Effective delivery of anti-PD-L1 siRNA with human heavy chain ferritin (HFn) in acute myeloid leukemia cell lines.
Rajabinejad M; Valadan R; Tehrani M; Najafi A; Negarandeh R; Saeedi M; Asgarian-Omran H
Med Oncol; 2024 May; 41(6):149. PubMed ID: 38739199
[TBL] [Abstract] [Full Text] [Related]
2. Second treatment-Free Remission Attempt in Patients with Chronic Myeloid leukemia.
Ureshino H; Kamachi K; Kimura S
Clin Lymphoma Myeloma Leuk; 2024 Apr; 24(4):e138-e141. PubMed ID: 38195325
[TBL] [Abstract] [Full Text] [Related]
3. System analysis of surface CD markers during the process of granulocytic differentiation.
Novikova SE; Tolstova TV; Soloveva NA; Farafonova TE; Tikhonova OV; Kurbatov LK; Rusanov AL; Zgoda VG
Biomed Khim; 2023 Dec; 69(6):383-393. PubMed ID: 38153053
[TBL] [Abstract] [Full Text] [Related]
4. Final report of TKI discontinuation trial with dasatinib for the second attempt of treatment-free remission after failing the first attempt with imatinib: treatment-free Remission Accomplished by Dasatinib (TRAD) study.
Perusini MA; Novitzky-Basso I; Atenafu EG; Forrest D; Bence-Bruckler I; Savoie L; Keating MM; Busque L; Delage R; Xenocostas A; Liew E; Laneuville P; Paulson K; Stockley T; Lipton JH; Leber B; Kim DDH
Br J Haematol; 2023 Dec; 203(5):781-791. PubMed ID: 37697469
[TBL] [Abstract] [Full Text] [Related]
5. A Systematic Review on Second treatment-Free Remission (TFR) Attempt in Chronic Myeloid leukemia (CML): Can it be Applied in Clinical Practice?
Çiftçiler R; Akın MG; Erat Z; Eşkazan AE
Clin Lymphoma Myeloma Leuk; 2023 Jan; 23(1):8-14. PubMed ID: 36344420
[TBL] [Abstract] [Full Text] [Related]
6. Immunomodulatory kits generating leukaemia derived dendritic cells do not induce blast proliferation ex vivo: IPO-38 as a novel marker to quantify proliferating blasts in acute myeloid leukaemia.
Plett C; Klauer LK; Amberger DC; Ugur S; Rabe A; Fischer Z; Deen D; Hirn-Lopez A; Gunsilius C; Werner JO; Schmohl J; Krämer D; Rank A; Schmid C; Schmetzer HM
Clin Immunol; 2022 Sep; 242():109083. PubMed ID: 35908638
[TBL] [Abstract] [Full Text] [Related]
7. Patient-specific molecular response dynamics can predict the possibility of relapse during the second treatment-free remission attempt in chronic myelogenous leukemia.
Kim E; Hwang EJ; Lee J; Kim DY; Kim JY; Kim DW
Neoplasia; 2022 Oct; 32():100817. PubMed ID: 35878453
[TBL] [Abstract] [Full Text] [Related]
8. Discovery of a Transferrin Receptor 1-Binding Aptamer and Its Application in Cancer Cell Depletion for Adoptive T-Cell Therapy Manufacturing.
Cheng EL; Cardle II; Kacherovsky N; Bansia H; Wang T; Zhou Y; Raman J; Yen A; Gutierrez D; Salipante SJ; des Georges A; Jensen MC; Pun SH
J Am Chem Soc; 2022 Aug; 144(30):13851-13864. PubMed ID: 35875870
[TBL] [Abstract] [Full Text] [Related]
9. Ferritin-based targeted delivery of arsenic to diverse leukaemia types confers strong anti-leukaemia therapeutic effects.
Wang C; Zhang W; He Y; Gao Z; Liu L; Yu S; Hu Y; Wang S; Zhao C; Li H; Shi J; Zhou W; Li F; Yue H; Li Y; Wei W; Ma G; Ma D
Nat Nanotechnol; 2021 Dec; 16(12):1413-1423. PubMed ID: 34697490
[TBL] [Abstract] [Full Text] [Related]
10. Successful treatment of a Patient with Chronic Myelogenous leukemia with Concurrent Janus Kinase 2 (JAK2) R795S Mutation and Breakpoint Cluster Region-ABL1 (BCR-ABL1) Fusion: A Case Report and Literature Review.
Yue Y; Wei W; Guo Y; Wang F; Dong W; Liu Y; Lin Y; Cao Y; Gu W
Am J Case Rep; 2020 Oct; 21():e925151. PubMed ID: 33021971
[TBL] [Abstract] [Full Text] [Related]
11. Novel lncRNA-IUR suppresses Bcr-Abl-induced tumorigenesis through regulation of STAT5-cd71 pathway.
Wang X; Yang J; Guo G; Feng R; Chen K; Liao Y; Zhang L; Sun L; Huang S; Chen JL
Mol Cancer; 2019 Apr; 18(1):84. PubMed ID: 30961617
[TBL] [Abstract] [Full Text] [Related]
12. A recycling anti-transferrin receptor-1 monoclonal antibody as an efficient therapy for erythroleukemia through target up-regulation and antibody-dependent cytotoxic effector functions.
Neiveyans M; Melhem R; Arnoult C; Bourquard T; Jarlier M; Busson M; Laroche A; Cerutti M; Pugnière M; Ternant D; Gaborit N; Chardès T; Poupon A; Gouilleux-Gruart V; Pèlegrin A; Poul MA
MAbs; 2019 Apr; 11(3):593-605. PubMed ID: 30604643
[TBL] [Abstract] [Full Text] [Related]
13. Induction of apoptosis and erythroid differentiation of human chronic myelogenous leukemia K562 cells by low concentrations of lidamycin.
Zhang C; Guo LY; Mu D; Gong JH; Chen J
Oncol Rep; 2019 Jan; 41(1):475-482. PubMed ID: 30542729
[TBL] [Abstract] [Full Text] [Related]
14. Late-stage tumors induce anemia and immunosuppressive extramedullary erythroid progenitor cells.
Zhao L; He R; Long H; Guo B; Jia Q; Qin D; Liu SQ; Wang Z; Xiang T; Zhang J; Tan Y; Huang J; Chen J; Wang F; Xiao M; Gao J; Yang X; Zeng H; Wang X; Hu C; Alexander PB; Symonds ALJ; Yu J; Wan Y; Li QJ; Ye L; Zhu B
Nat Med; 2018 Oct; 24(10):1536-1544. PubMed ID: 30297899
[TBL] [Abstract] [Full Text] [Related]
15. Basophil-lineage commitment in acute promyelocytic leukemia predicts for severe bleeding after starting therapy.
Matarraz S; Leoz P; Fernández C; Colado E; Chillón MC; Vidriales MB; González M; Rivera D; Osuna CS; Caballero-Velázquez T; Van Der Velden V; Jongen-Lavrencic M; Gutiérrez O; Bermejo AY; Alonso LG; García MB; De Ramón Sánchez C; García-Donas G; Mateo AG; Recio I; Sánchez-Real J; Mayado A; Gutiérrez ML; Bárcena P; Barrena S; López A; Van Dongen J; Orfao A
Mod Pathol; 2018 Aug; 31(8):1318-1331. PubMed ID: 29572500
[TBL] [Abstract] [Full Text] [Related]
16. Development of a complete human IgG monoclonal antibody to transferrin receptor 1 targeted for adult T-cell leukemia/lymphoma.
Shimosaki S; Nakahata S; Ichikawa T; Kitanaka A; Kameda T; Hidaka T; Kubuki Y; Kurosawa G; Zhang L; Sudo Y; Shimoda K; Morishita K
Biochem Biophys Res Commun; 2017 Mar; 485(1):144-151. PubMed ID: 28189691
[TBL] [Abstract] [Full Text] [Related]
17. [Effect of TBLR1-RARα Fusion Gene on Erythroid Differentiation of K562 Cells].
Chen J; Li H; An N; Li SY; Lu WT; Xing HY; Rao Q; Wang M; Wang JX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Dec; 23(6):1702-8. PubMed ID: 26708897
[TBL] [Abstract] [Full Text] [Related]
18. Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: 10-Color flow cytometry diagnosis and HyperCVAD therapy.
Deotare U; Yee KW; Le LW; Porwit A; Tierens A; Musani R; Barth D; Torlakovic E; Schimmer A; Schuh AC; Seftel M; Minden MD; Gupta V; Hyjek E
Am J Hematol; 2016 Mar; 91(3):283-6. PubMed ID: 26619305
[TBL] [Abstract] [Full Text] [Related]
19. Novel agent nitidine chloride induces erythroid differentiation and apoptosis in CML cells through c-Myc-miRNAs axis.
Liu N; Li P; Zang S; Liu Q; Ma D; Sun X; Ji C
PLoS One; 2015; 10(2):e0116880. PubMed ID: 25647305
[TBL] [Abstract] [Full Text] [Related]
20. Persistence of cisplatin-induced mutagenicity in hematopoietic stem cells: implications for secondary cancer risk following chemotherapy.
Dertinger SD; Avlasevich SL; Torous DK; Bemis JC; Phonethepswath S; Labash C; Carlson K; Mereness J; Cottom J; Palis J; MacGregor JT
Toxicol Sci; 2014 Aug; 140(2):307-14. PubMed ID: 24798381
[TBL] [Abstract] [Full Text] [Related]
[Next]
